Alumis
Marie (Jennifer) Cortes is an experienced Senior Executive Assistant with a strong background in the biopharmaceutical sector, currently serving at Alumis since December 2021, where the focus is on developing oral therapies for patients with immune-mediated diseases. Prior experience includes roles at Sanofi (September 2020 - December 2021) and Principia Biopharma, where responsibilities extended to supporting C-level executives and site heads. Additional positions span various biopharma companies, including Myovant Sciences, Immune Design, and Titan Pharmaceuticals, highlighting expertise in administrative support, office management, and strategic collaboration. Marie holds an MBA in Health Care Administration and a Bachelor of Science in Business Management from the University of Phoenix.
This person is not in any teams
Alumis
2 followers
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.